Interim audit report of the physical and financial part of the project
On October 1, 2022, the interim audit report of the physical and financial part of the project was submitted.
Development of Targeted Hormone-Dependent Cancer Therapy
On October 1, 2022, the interim audit report of the physical and financial part of the project was submitted.
The new project completion date (due to a 6-month extension) is October 29, 2023